T-cells in alzheimer’s disease (original) (raw)

• Anders K. H., Wang Z. Z., Kornfeld M., et al. (1997) Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies. Hum. Pathol. 28, 1237–1246.
  Article PubMed CAS Google Scholar
• Archambault A. S., Sim J., Gimenez M. A., and Russell J. H. (2005) Defining antigen-dependent stages of T cell migration from the blood to the central nervous system parenchyma. Eur. J. Immunol. 35, 1076–1085.
  Article PubMed CAS Google Scholar
• Baril L., Nicolas L., Croisile B., et al. (2004) Immune response to Abeta-peptides in peripheral blood from patients with Alzheimer’s disease and control subjects. Neurosci. Lett. 355, 226–230.
  Article PubMed CAS Google Scholar
• Becker K. J., McCarron R. M., Ruetzler C., et al. (1997) Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 94, 10,873–10,878.
  Article CAS Google Scholar
• Bongioanni P., Boccardi B., Borgna M., Castagna M., and Mondino C. (1997) T-cell interferon gamma binding in patients with dementia of the Alzheimer type. Arch. Neurol. 54, 457–462.
  PubMed CAS Google Scholar
• Cribbs D. H., Ghochikyan A., Vasilevko V., et al. (2003) Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid. Int. Immunol. 15, 505–514.
  Article PubMed CAS Google Scholar
• Das P., Murphy M. P., Younkin L. H., Younkin S. G., and Golde T. E. (2001) Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol. Aging 22, 721–727.
  Article PubMed CAS Google Scholar
• Dong C. and Flavell R. A. (2001) Th1 and Th2 cells. Curr. Opin. Hematol. 8, 47–51.
  Article PubMed CAS Google Scholar
• Dutton R. W., Bradley L. M., and Swain S. L. (1998) T cell memory. Annu. Rev. Immunol. 16, 201–223.
  Article PubMed CAS Google Scholar
• Ellis R. J., Olichney J. M., Thal L. J., et al. (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 46, 1592–1596.
  PubMed CAS Google Scholar
• Eng J. A., Frosch M. P., Choi K., Rebeck G. W., and Greenberg S. M. (2004) Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann. Neurol. 55, 250–256.
  Article PubMed Google Scholar
• Furlan R., Brambilla E., Sanvito F., et al. (2003) Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain 126, 285–291.
  Article PubMed Google Scholar
• Gruden M. A., Davudova T. B., Malisauskas M., et al. (2004) Autoimmune responses to amyloid structures of Abeta(25–35) peptide and human lysozyme in the serum of patients with progressive Alzheimer’s disease. Dement. Geriatr. Cogn. Disord. 18, 165–171.
  Article PubMed CAS Google Scholar
• Hickey W. F. (2001) Basic principles of immunological surveillance of the normal central nervous system. Glia 36, 118–124.
  Article PubMed CAS Google Scholar
• Huberman M., Sredni B., Stern L., Kott E., and Shalit F. (1995) IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease. J. Neurol. Sci. 130, 161–164.
  Article PubMed CAS Google Scholar
• Hyman B. T., Smith C., Buldyrev I., et al. (2001) Autoantibodies to amyloid-beta and Alzheimer’s disease. Ann. Neurol. 49, 808–810.
  Article PubMed CAS Google Scholar
• Janus C., Pearson J., McLaurin J., et al. (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature 408, 979–982.
  Article PubMed CAS Google Scholar
• Jones T. B., Basso D. M., Sodhi A., et al. (2002) Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J. Neurosci. 22, 2690–2700.
  PubMed CAS Google Scholar
• Kim H. D., Cao Y., Kong F. K., et al. (2005) Induction of a Th2 immune response by co-administration of recombinant adenovirus vectors encoding amyloid beta-protein and GM-CSF. Vaccine 23, 2977–2986.
  Article PubMed CAS Google Scholar
• Lafaille J. J. (1998) The role of helper T cell subsets in autoimmune diseases. Cytokine Growth Factor Rev. 9, 139–151.
  Article PubMed CAS Google Scholar
• Lemere C. A., Maron R., Selkoe D. J., and Weiner H. L. (2001) Nasal vaccination with beta-amyloid peptide for the treatment of Alzheimer’s disease. DNA Cell Biol. 20, 705–711.
  Article PubMed CAS Google Scholar
• Lemere C. A., Maron R., Spooner E. T., et al. (2000) Nasal A beta treatment induces anti-A beta antibody production and decreases cerebral amyloid burden in PD-APP mice. Ann. NY. Acad. Sci. 920, 328–331.
  Article PubMed CAS Google Scholar
• Linton P. J., Haynes L., Klinman N. R., and Swain S. L. (1996) Antigen-independent changes in naive CD4 T cells with aging. J. Exp. Med. 184, 1891–1900.
  Article PubMed CAS Google Scholar
• Lombardi V. R., Fernandez-Novoa L., Etcheverria I., Seoane S., and Cacabelos R. (2004) Association between APOE epsilon4 allele and increased expression of CD95 on T cells from patients with Alzheimer’s disease. Methods Find. Exp. Clin. Pharmacol. 26, 523–529.
  Article PubMed CAS Google Scholar
• Lombardi V. R., Garcia M., Rey L., and Cacabelos R. (1999) Characterization of cytokine production, screening of lymphocyte subset patterns and in vitro apoptosis in healthy and Alzheimer’s Disease (AD) individuals. J. Neuroimmunol. 97, 163–171.
  Article PubMed CAS Google Scholar
• Lopez O. L., Rabin B. S., and Huff F. J. (1991) Serum auto-antibodies in Alzheimer’s disease. Acta Neurol. Scand. 84, 441–444.
  Article PubMed CAS Google Scholar
• McGeer E. G. and McGeer P. L. (1999a) Brain inflammation in Alzheimer disease and the therapeutic implications. Curr. Pharm. Des. 5, 821–836.
  PubMed CAS Google Scholar
• McGeer P. L. and McGeer E. G. (1999b) Inflammation of the brain in Alzheimer’s disease: implications for therapy. J. Leukoc. Biol. 65, 409–415.
  PubMed CAS Google Scholar
• McGeer P. L. and McGeer E. G. (2002) Innate immunity, local inflammation, and degenerative disease. Sci. Aging Knowledge Environ. 2002(29), re3.
  Google Scholar
• Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I. R., and Schwartz M. (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 5, 49–55.
  Article PubMed CAS Google Scholar
• Monsonego A., Imitola J., Zota V., Oida T., and Weiner H. L. (2003a) Microglia-mediated nitric oxide cytotoxicity of T cells following amyloid beta-peptide presentation to Th1 cells. J. Immunol. 171, 2216–2224.
  PubMed CAS Google Scholar
• Monsonego A., Maron R., Zota V., Selkoe D. J., and Weiner H. L. (2001) Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA 98, 10273–10278.
  Article PubMed CAS Google Scholar
• Monsonego A., Zota V., Karni A, et al. (2003b) Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease. J. Clin. Invest. 112, 415–422.
  Article PubMed CAS Google Scholar
• Morgan D., Diamond D. M., Gottschall P. E., et al. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature 408, 982–985.
  Article PubMed CAS Google Scholar
• Mruthinti S., Buccafusco J. J., Hill W. D., et al. (2004) Autoimmunity in Alzheimer’s disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol. Aging 25, 1023–1032.
  Article PubMed CAS Google Scholar
• Myagkova M. A., Gavrilova S. I., Lermontova N. N., et al. (2003) Content of autoantibodies to bradykinin and beta-amyloid(1–42) as a criterion for biochemical differences between Alzheimer’s dementias. Bull. Exp. Biol. Med. 136, 49–52.
  Article PubMed CAS Google Scholar
• Nagelkerken L. (1998) Role of Th1 and Th2 cells in autoimmune demyelinating disease. Braz. J. Med. Biol. Res. 31, 55–60.
  Article PubMed CAS Google Scholar
• Nath A., Hall E., Tuzova M., et al. (2003) Autoantibodies to amyloid beta-peptide (A beta) are increased in Alzheimer’s disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development. Neuromol. Med. 3, 29–39.
  Article CAS Google Scholar
• Nicoll J. A., Wilkinson D., Holmes C., Steart P., Markham H., and Weller R. O. (2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med. 9, 448–452.
  Article PubMed CAS Google Scholar
• Peterson D. A., DiPaolo R. J., Kanagawa O., and Unanue E. R. (1999) Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity 11, 453–462.
  Article PubMed CAS Google Scholar
• Pfeifer M., Boncristiano S., Bondolfi L., et al. (2002) Cerebral hemorrhage after passive anti-Abeta immunotherapy. Science 298, 1379.
  Article PubMed CAS Google Scholar
• Qu B., Rosenberg R. N., Li L., Boyer P. J., and Johnston S. A. (2004) Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease. Arch. Neurol. 61, 1859–1864.
  Article PubMed Google Scholar
• Rogers J., Luber-Narod J., Styren S. D., and Civin W. H. (1988) Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer’s disease. Neurobiol. Aging 9, 339–349.
  Article PubMed CAS Google Scholar
• Rogers J., Webster S., Lue L. F., et al. (1996) Inflammation and Alzheimer’s disease pathogenesis. Neurobiol. Aging 17, 681–686.
  Article PubMed CAS Google Scholar
• Romagnani S. (1992) Human TH1 and TH2 subsets: regulation of differentiation and role in protection and immunopathology. Int. Arch. Allergy Immunol. 98, 279–285.
  Article PubMed CAS Google Scholar
• Romagnani S. (2000) T-cell subsets (Th1 versus Th2) Ann. Allergy Asthma Immunol. 85, 9–18; quiz 18, 21.
  Article PubMed CAS Google Scholar
• Schenk D., Barbour R., Dunn W., et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173–177.
  Article PubMed CAS Google Scholar
• Scolding N. J., Joseph F., Kirby P. A., et al. (2005) Abetarelated angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain 128, 500–515.
  Article PubMed Google Scholar
• Shalit F., Sredni B., Stern L., Kott E., and Huberman M. (1994) Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer’s patients. Neurosci. Lett. 174, 130–132.
  Article PubMed CAS Google Scholar
• Tan J., Town T., Abdullah L., et al. (2002a) CD45 isoform alteration in CD4+ T cells as a potential diagnostic marker of Alzheimer’s disease. J. Neuroimmunol. 132, 164–172.
  Article PubMed CAS Google Scholar
• Tan J., Town T., Crawford F., et al. (2002b) Role of CD40 ligand in amyloidosis in transgenic Alzheimer’s mice. Nat. Neurosci. 5, 1288–1293.
  Article PubMed CAS Google Scholar
• Tan J., Town T., and Mullan M. (2002c) CD40-CD40L interaction in Alzheimer’s disease. Curr. Opin. Pharmacol. 2, 445–451.
  Article PubMed CAS Google Scholar
• Tan J., Town T., Paris D., et al. (1999a) Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science 286, 2352–2355.
  Article PubMed CAS Google Scholar
• Tan J., Town T., Suo Z., et al. (1999b) Induction of CD40 on human endothelial cells by Alzheimer’s beta-amyloid peptides. Brain Res. Bull. 50, 143–148.
  Article PubMed CAS Google Scholar
• Tarkowski E., Wallin A., Regland B., Blennow K., and Tarkowski A. (2001) Local and systemic GM-CSF increase in Alzheimer’s disease and vascular dementia. Acta. Neurol. Scand. 103, 166–174.
  Article PubMed CAS Google Scholar
• Togo T., Akiyama H., Iseki E., et al. (2002) Occurrence of T cells in the brain of Alzheimer’s disease and other neurological diseases. J. Neuroimmunol. 124, 83–92.
  Article PubMed CAS Google Scholar
• Town T., Tan J., and Mullan M. (2001a) CD40 signaling and Alzheimer’s disease pathogenesis. Neurochem. Int. 39, 371–380.
  Article PubMed CAS Google Scholar
• Town T., Tan J., Sansone N., Obregon D., Klein T., and Mullan M. (2001b) Characterization of murine immunoglobulin G antibodies against human amyloid-beta1-42 Neurosci. Lett. 307, 101–104.
  Article PubMed CAS Google Scholar
• Town T., Vendrame M., Patel A., et al. (2002) Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer’s beta-amyloid(1–42). J. Neuroimmunol. 132, 49–59.
  Article PubMed CAS Google Scholar
• Townsend K. P., Town T., Mori T., et al. (2005) CD40 signaling regulates innate and adaptive activation of microglia in response to amyloid beta-peptide. Eur. J. Immunol. 35, 901–910.
  Article PubMed CAS Google Scholar
• Weiner H. L., Lemere C. A., Maron R., et al. (2000) Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer’s disease. Ann. Neurol. 48, 567–579.
  Article PubMed CAS Google Scholar
• Wyss-Coray T., Lin C., Yan F., et al. (2001) TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat. Med. 7, 612–618.
  Article PubMed CAS Google Scholar
• Yamada M., Itoh Y., Shintaku M., et al. (1996) Immune reactions associated with cerebral amyloid angiopathy. Stroke 27, 1155–1162.
  PubMed CAS Google Scholar
• Zhang J., Wu X., Qin C., et al. (2003) A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of Alzheimer’s disease. Neurobiol. Dis. 14, 365–379.
  Article PubMed CAS Google Scholar